Mirza Mansoor Raza — SEC Form 4 filings

SEC reporting owner CIK 1588389. 25 Form 4 filings on record with FilingPulse; latest filed 2026-07-14.

Transaction summary — filings shown

Covers all 25 filings on record, filed 2024-05-30 to 2026-07-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
SERA PROGNOSTICS, INC. (SERA)Director2017 legs · 2,522 sh · $10,04910
Acrivon Therapeutics, Inc. (ACRV)Chief Medical Officer33
Karyopharm Therapeutics Inc. (KPTI)Director22

Form 4 filings — Mirza Mansoor Raza

FiledFormIssuerReported transactionsSource
2026-07-144SERA PROGNOSTICS, INC. (SERA)Grant/award (A): 22,426 @ $0 · Grant/award (A): 1,771 @ $0 · Grant/award (A): 34,494 (derivative) @ $0 · Grant/award (A): 2,725 (derivative) @ $0EDGAR
2026-05-204Acrivon Therapeutics, Inc. (ACRV)Grant/award (A): 38,817 @ $0EDGAR
2026-03-034Acrivon Therapeutics, Inc. (ACRV)Grant/award (A): 174,068 (derivative) @ $0EDGAR
2025-12-054SERA PROGNOSTICS, INC. (SERA)Sale (S): 292 @ $3.05EDGAR
2025-11-064SERA PROGNOSTICS, INC. (SERA)Sale (S): 221 @ $3.04EDGAR
2025-10-064SERA PROGNOSTICS, INC. (SERA)Sale (S): 227 @ $3.16EDGAR
2025-10-034Acrivon Therapeutics, Inc. (ACRV)Grant/award (A): 225,000 (derivative) @ $0EDGAR
2025-09-054SERA PROGNOSTICS, INC. (SERA)Sale (S): 222 @ $3.35EDGAR
2025-08-054SERA PROGNOSTICS, INC. (SERA)Sale (S): 225 @ $2.50EDGAR
2025-07-084SERA PROGNOSTICS, INC. (SERA)Sale (S): 234 @ $2.36EDGAR
2025-06-064SERA PROGNOSTICS, INC. (SERA)Grant/award (A): 15,596 @ $0 · Sale (S): 107 @ $1.58 · Grant/award (A): 25,000 (derivative) @ $0EDGAR
2025-05-294Karyopharm Therapeutics Inc. (KPTI)Grant/award (A): 4,600 (derivative) @ $0EDGAR
2025-05-094SERA PROGNOSTICS, INC. (SERA)Sale (S): 106 @ $2.44EDGAR
2025-04-084SERA PROGNOSTICS, INC. (SERA)Sale (S): 107 @ $3.35EDGAR
2025-03-074SERA PROGNOSTICS, INC. (SERA)Sale (S): 99 @ $4.16EDGAR
2025-02-144SERA PROGNOSTICS, INC. (SERA)Sale (S): 101 @ $4.58EDGAR
2025-01-274SERA PROGNOSTICS, INC. (SERA)Option exercise (M): 37,549 @ $0.91 · Option exercise (M): 37,549 (derivative) @ $0EDGAR
2025-01-074SERA PROGNOSTICS, INC. (SERA)Sale (S): 100 @ $7.69EDGAR
2024-12-094SERA PROGNOSTICS, INC. (SERA)Sale (S): 93 @ $7.12EDGAR
2024-11-124SERA PROGNOSTICS, INC. (SERA)Sale (S): 95 @ $7.32EDGAR
2024-10-074SERA PROGNOSTICS, INC. (SERA)Sale (S): 96 @ $7.15EDGAR
2024-09-094SERA PROGNOSTICS, INC. (SERA)Sale (S): 96 @ $7.16EDGAR
2024-08-084SERA PROGNOSTICS, INC. (SERA)Sale (S): 101 @ $7.42EDGAR
2024-06-074SERA PROGNOSTICS, INC. (SERA)Grant/award (A): 7,117 @ $0 · Grant/award (A): 10,549 (derivative) @ $0EDGAR
2024-05-304Karyopharm Therapeutics Inc. (KPTI)Grant/award (A): 69,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1588389 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →